3D Cell Culture Market | Strategies Adopted by Leading Companies for Revenue Growth |Thermo Fisher (US) and Corning (US) are the Leading Player

Thermo Fisher (US) and Corning (US) are the Leading Player in the 3D Cell Culture Market

The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of this market.

Agreements, partnerships, and collaborations accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Mimetas (Netherlands), Emulate (US), and Lonza (Switzerland).

Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

The 3D cell culture market is highly competitive with several big and small players. Prominent players in this market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US.), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

Thermo Fisher was the leading player in the 3D cell culture market in 2016. The company’s leading position is primarily attributed to its strong brand image and product portfolio. Thermo Fisher constantly focuses on strengthening its product portfolio. For instance, in 2014, the company introduced Nunclon Sphera, a polymer-coated cell culture surface with low-binding characteristics, which supports the growth of 3D cancer spheroids and embryoid bodies. The company has a strong presence in over 100 countries across the Americas, Asia Pacific, Europe, and the Middle East & Africa.

Corning was the second-largest leading player in the global 3D cell culture market in 2016. The leading position of the company is attributed to its robust product portfolio which includes scaffold-based and scaffold-free products. To maintain its strong position in the market, the company focuses on adopting organic and inorganic growth strategies such as expansions, agreements, partnerships, and collaborations. For instance, in November 2015, Corning established its distribution center in Shanghai, China. Corning, Flacon, and Axygen are some of the leading brands available through this center. This enabled company to expand its market presence in the emerging Asian market. Moreover, to sustain its presence, the company focuses on collaborating with prominent players operating in this market. In this regard, in March 2014, Corning agreed with American Type Culture Collection (ATCC) to co-develop and co-market new applications for current ATCC and Corning products.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847

Top 10 Medical Device Technologies Which Booming in 2019

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IV

In Situ Hybridization Market Growth Analysis - Global Forecast To 2021

According to the new market research report " In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected to account for the largest share of the global market. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, g

Home Healthcare Market - Global Forecast to 2022 | CAGR of 8.8%

According to the new market research report " Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. Don’t miss out on business opportunities in Home Healthcare Market . Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=696 The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 220.67 Billion in 2016, at a CAGR of 8.8%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The objectives of this study are as follows: To define, describe, segment and forecast the

Healthcare Industry Trends and Updates

Search This Blog